Icon

ABRAXANE (nda021660)- (100MG/VIAL)

PACLITAXEL BRISTOL-MYERS
100MG/VIAL
Yes Yes
2034-Jul-12 Expired
None None
None No
ABRAXANEâ„¢ for Injectable Suspension (paclitaxel protein-bound particles for injectable suspension) is indicated for the treatment of breast cancer after failure of combination chemotherapy for metastatic disease or relapse within 6 months of adjuvant chemotherapy.
1 0 1
Total Other Developers 3
Drugs with Suitability No
100MG/VIAL ** ** - - -
NDA Sales Available Total Generic Sales Available
Yes 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** ******* ****** ******* ******* *************** **., ***. (******* **** ****) *********** ** ******* ****, ******** & ************* *********** ****,, ***********, ******* ******, ***** (***) ***

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.